2m 2m 2m 2m 2m 2m 2m
ELANC ANIML HLTH (ELAN)
NYSE
$26.48-$0.29 (-1.07%)
Price as of Nov 11, 2026 7:56 PM EST- $13.4BMarket Cap
- 17.06%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ELANC ANIML HLTH (ELAN)
$26.48-$0.29 (-1.07%)
ELAN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.76 | ||
Change | -$0.08 (-0.30%) | ||
Open | $26.67 | ||
High | $27.14 | ||
Low | $26.33 | ||
Previous Close | $26.84 | ||
Volume | 5,198,825 | ||
30-Day Average Volume | 5,552,910 | ||
1-Week Change | 8.91% | ||
1-Month Change | 16.75% | ||
1-Year Change | 17.06% | ||
3-Year Change | 150.56% | ||
5-Year Change | -18.86% | ||
Fundamentals | |||
Shares Outstanding | 499.8M | ||
Total Assets | $13.3B | ||
Market Cap | $13.4B | ||
Enterprise Value | $16.6B | ||
Period: QTR TTM FY | |||
Revenue | $1.3B | ||
Net Income | $18.0M | ||
Free Cash Flow | $156.0M | ||
EBIT | $24.0M | ||
EBITDA | $201.0M | ||
Net Working Capital | $1.9B | ||
EPS | $0.04 | ||
Enterprise Value/EBITDA | 83 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 2 | ||
P/E | 669 | ||
PEG | -11 | ||
Price/Free Cash Flow | 86 | ||
Price/Operating Cash Flow | 62 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue